Answers are grounded in this paper and cite their sources.
A BSTRACT Infectious diseases remain a major global challenge due to pathogen evolution, antimicrobial resistance, and emerging threats. Conventional therapies are often limited by broad-spectrum toxicity and declining efficacy, underscoring the urgent need for precision strategies. Originally developed for oncology, antibody-based targeted conjugates (ABTCs) – including antibody-drug conjugates (ADCs) offer a promising platform that pairs monoclonal antibody specificity with diverse therapeutic payloads for targeted delivery. This narrative review was informed by a structured search of PubMed/MEDLINE, Web of Science, and Scopus from database inception through June 2026, with studies selected for their relevance to antibody- or Fc-based targeted payload delivery and classified as clinical, preclinical in vivo, in vitro proof-of-concept, or conceptual/emerging evidence. This review explores the emerging application of ABTCs as anti-infective agents, focusing on their potential to selectively target pathogens, eliminate infected host cells, or modulate host pathways critical for infection. Key design considerations, including antibody selection, linker chemistry, and payload diversification are discussed in the context of infectious disease biology. We further highlight current applications, including pathogen-targeted, infected cell-directed, and host-directed ABTCs approaches, as well as ADC-inspired antiviral strategies incorporating noncytotoxic and immunomodulatory payloads. Despite promising preclinical advances, significant barriers remain, including target identification, delivery limitations, safety concerns, and infection-specific pharmacokinetics. Overall, anti-infective ABTCs represent a conceptual shift toward precision therapeutics. Continued interdisciplinary innovation will be essential to translate this platform into clinically effective treatments for infectious diseases.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: